Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors

被引：0
|
作者：
Sabina Sandigursky
Adam Mor
机构：
[1] NYU School of Medicine,Department of Medicine
[2] NYU School of Medicine,Perlmutter Cancer Center
[3] Columbia University Medical Center,Columbia Center for Translational Immunology, Department of Medicine
来源：
Current Rheumatology Reports | 2018年 / 20卷
关键词：
Cancer; Checkpoint inhibitors; Adverse events; Autoimmune; irAEs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [2] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [3] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [4] Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Klein, Brittany A.
    Alves, Fabio Abreu
    de Santana Rodrigues Velho, Julia
    Vacharotayangul, Piamkamon
    Hanna, Glenn J.
    LeBoeuf, Nicole R.
    Shazib, Muhammad Ali
    Villa, Alessandro
    Woo, Sook-Bin
    Sroussi, Herve
    Sonis, Stephen
    Treister, Nathaniel S.
    ORAL DISEASES, 2022, 28 (01) : 9 - 22
  • [5] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lee, David J.
    Lee, Howard J., Jr.
    Farmer, Jocelyn R.
    Reynolds, Kerry L.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (08)
  • [6] Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
    David J. Lee
    Howard J. Lee
    Jocelyn R. Farmer
    Kerry L. Reynolds
    Current Cardiology Reports, 2021, 23
  • [7] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [8] Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
    Cheema, Parneet K.
    Iafolla, Marco A. J.
    Abdel-Qadir, Husam
    Bellini, Andrew B.
    Chatur, Nazira
    Chandok, Natasha
    Comondore, Vikram R.
    Cunningham, Morven
    Halperin, Ilana
    Hu, Anne B.
    Jaskolka, Diana
    Darvish-Kazem, Saeed
    Khandaker, Masud H.
    Kitchlu, Abhijat
    Sachdeva, Jasdip S.
    Shapera, Shane
    Woolnough, Nicholas R. J.
    Nematollahi, Massey
    CURRENT ONCOLOGY, 2024, 31 (10) : 6356 - 6383
  • [9] PHYSICIAN AWARENESS OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Araujo, F.
    Fonseca, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1777 - 1778
  • [10] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
12345